EQAPOL SARS CoV-2 Option 44
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
National Institutes of Health
Start Date
September 30, 2021
End Date
September 29, 2022
Administered By
Duke Human Vaccine Institute
Awarded By
National Institutes of Health
Start Date
September 30, 2021
End Date
September 29, 2022